 Paul Buehler
Concepts (479)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 65 | 2024 | 353 | 10.920 |
Why?
| | Haptoglobins | 23 | 2022 | 53 | 4.260 |
Why?
| | Hemopexin | 11 | 2025 | 27 | 3.510 |
Why?
| | Anemia, Sickle Cell | 17 | 2025 | 270 | 3.500 |
Why?
| | Oxygen | 26 | 2024 | 931 | 3.240 |
Why?
| | Erythrocytes | 26 | 2025 | 700 | 3.230 |
Why?
| | Blood Substitutes | 15 | 2024 | 27 | 2.760 |
Why?
| | Hemolysis | 21 | 2025 | 206 | 2.660 |
Why?
| | Erythrocyte Transfusion | 9 | 2024 | 194 | 2.140 |
Why?
| | Extracellular Vesicles | 3 | 2023 | 146 | 1.940 |
Why?
| | Thrombin | 7 | 2023 | 152 | 1.930 |
Why?
| | Heme | 15 | 2025 | 78 | 1.860 |
Why?
| | Guinea Pigs | 23 | 2024 | 158 | 1.790 |
Why?
| | Iron | 17 | 2025 | 313 | 1.590 |
Why?
| | Fibrinolysin | 4 | 2022 | 20 | 1.520 |
Why?
| | Homeostasis | 3 | 2020 | 621 | 1.440 |
Why?
| | Transferrin | 5 | 2025 | 47 | 1.430 |
Why?
| | Kidney | 13 | 2020 | 1468 | 1.380 |
Why?
| | Oxidation-Reduction | 26 | 2020 | 1060 | 1.270 |
Why?
| | Complement C1 Inhibitor Protein | 4 | 2023 | 11 | 1.180 |
Why?
| | Animals | 80 | 2025 | 36940 | 1.110 |
Why?
| | Blood Preservation | 10 | 2023 | 285 | 1.090 |
Why?
| | Blood Transfusion | 6 | 2021 | 325 | 1.090 |
Why?
| | Oxyhemoglobins | 5 | 2021 | 23 | 0.980 |
Why?
| | Thrombosis | 4 | 2022 | 371 | 0.970 |
Why?
| | Oximetry | 3 | 2021 | 96 | 0.900 |
Why?
| | Hydrogen Peroxide | 12 | 2021 | 328 | 0.880 |
Why?
| | Thrombomodulin | 3 | 2022 | 10 | 0.840 |
Why?
| | Thrombotic Microangiopathies | 2 | 2020 | 20 | 0.810 |
Why?
| | Apoproteins | 3 | 2020 | 15 | 0.800 |
Why?
| | Electron Spin Resonance Spectroscopy | 6 | 2023 | 95 | 0.780 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 106 | 0.780 |
Why?
| | Oxidative Stress | 16 | 2025 | 1317 | 0.760 |
Why?
| | Cation Transport Proteins | 3 | 2022 | 134 | 0.750 |
Why?
| | Drug Design | 3 | 2021 | 167 | 0.730 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 167 | 0.720 |
Why?
| | Ascorbic Acid | 6 | 2019 | 177 | 0.720 |
Why?
| | Antibodies, Bispecific | 1 | 2021 | 55 | 0.690 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 15 | 0.680 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2020 | 13 | 0.680 |
Why?
| | Hematologic Diseases | 2 | 2018 | 62 | 0.680 |
Why?
| | Nitric Oxide | 11 | 2021 | 915 | 0.680 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 7 | 2021 | 61 | 0.660 |
Why?
| | Polymers | 6 | 2024 | 490 | 0.650 |
Why?
| | Lipids | 3 | 2023 | 672 | 0.650 |
Why?
| | Recombinant Proteins | 4 | 2021 | 1353 | 0.640 |
Why?
| | Humans | 92 | 2025 | 137585 | 0.630 |
Why?
| | Hemophilia A | 1 | 2021 | 139 | 0.630 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 173 | 0.600 |
Why?
| | Vascular Diseases | 3 | 2024 | 243 | 0.590 |
Why?
| | Receptors, Cell Surface | 7 | 2021 | 385 | 0.570 |
Why?
| | Transfusion Reaction | 3 | 2020 | 45 | 0.570 |
Why?
| | Antigens, CD | 7 | 2021 | 521 | 0.540 |
Why?
| | beta-Thalassemia | 3 | 2025 | 36 | 0.540 |
Why?
| | Lipoproteins | 1 | 2018 | 168 | 0.540 |
Why?
| | Biomarkers | 6 | 2020 | 4149 | 0.520 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 153 | 0.500 |
Why?
| | Lung | 6 | 2025 | 4060 | 0.490 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 815 | 0.480 |
Why?
| | Hemochromatosis | 1 | 2015 | 11 | 0.470 |
Why?
| | beta-Globins | 1 | 2015 | 8 | 0.470 |
Why?
| | Spleen | 4 | 2025 | 514 | 0.460 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 32 | 0.450 |
Why?
| | Hypertension, Pulmonary | 5 | 2025 | 1910 | 0.440 |
Why?
| | Glutaral | 3 | 2012 | 16 | 0.420 |
Why?
| | Exercise Tolerance | 3 | 2025 | 279 | 0.420 |
Why?
| | Rats, Sprague-Dawley | 10 | 2024 | 2486 | 0.420 |
Why?
| | Disease Models, Animal | 14 | 2025 | 4295 | 0.410 |
Why?
| | Inflammation | 4 | 2023 | 2837 | 0.410 |
Why?
| | Gene Deletion | 1 | 2015 | 391 | 0.410 |
Why?
| | Rats | 15 | 2024 | 5647 | 0.400 |
Why?
| | Peroxidases | 3 | 2015 | 34 | 0.400 |
Why?
| | Models, Animal | 4 | 2020 | 384 | 0.390 |
Why?
| | Polyethylene Glycols | 5 | 2024 | 641 | 0.390 |
Why?
| | Receptors, Scavenger | 6 | 2021 | 23 | 0.380 |
Why?
| | Blood Coagulation | 4 | 2022 | 255 | 0.380 |
Why?
| | Macrophages | 6 | 2023 | 1547 | 0.380 |
Why?
| | Male | 40 | 2025 | 67762 | 0.370 |
Why?
| | Cattle | 9 | 2022 | 984 | 0.360 |
Why?
| | Sodium Nitrite | 1 | 2011 | 39 | 0.350 |
Why?
| | Central Nervous System Diseases | 1 | 2011 | 69 | 0.340 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 278 | 0.330 |
Why?
| | Drug Carriers | 2 | 2008 | 128 | 0.330 |
Why?
| | Mice | 17 | 2025 | 17787 | 0.330 |
Why?
| | Biopolymers | 1 | 2010 | 31 | 0.320 |
Why?
| | Heme Oxygenase-1 | 8 | 2025 | 64 | 0.320 |
Why?
| | Heme Oxygenase (Decyclizing) | 6 | 2013 | 22 | 0.320 |
Why?
| | Biological Transport | 2 | 2021 | 418 | 0.320 |
Why?
| | Biological Products | 3 | 2022 | 216 | 0.320 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 144 | 0.310 |
Why?
| | Lung Diseases | 2 | 2015 | 767 | 0.310 |
Why?
| | Molecular Weight | 6 | 2024 | 335 | 0.310 |
Why?
| | Protein Binding | 8 | 2021 | 2224 | 0.310 |
Why?
| | Central Nervous System | 1 | 2011 | 258 | 0.310 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1000 | 0.310 |
Why?
| | Erythrocyte Deformability | 2 | 2023 | 19 | 0.310 |
Why?
| | Hemodynamics | 4 | 2023 | 1113 | 0.300 |
Why?
| | Amino Acids | 4 | 2021 | 497 | 0.300 |
Why?
| | Microvessels | 2 | 2020 | 88 | 0.290 |
Why?
| | Liver | 4 | 2025 | 1943 | 0.290 |
Why?
| | Endothelial Cells | 4 | 2024 | 785 | 0.290 |
Why?
| | Hypoxia | 6 | 2019 | 1112 | 0.280 |
Why?
| | Proteome | 3 | 2025 | 472 | 0.280 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 30 | 0.280 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 60 | 0.280 |
Why?
| | Plasma Exchange | 1 | 2007 | 14 | 0.280 |
Why?
| | Erythropoiesis | 2 | 2019 | 55 | 0.270 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2057 | 0.270 |
Why?
| | Proteomics | 7 | 2025 | 1111 | 0.270 |
Why?
| | Signal Transduction | 4 | 2019 | 5079 | 0.260 |
Why?
| | Uric Acid | 1 | 2008 | 163 | 0.260 |
Why?
| | Myocardium | 4 | 2019 | 1002 | 0.250 |
Why?
| | Blood Circulation | 1 | 2005 | 41 | 0.240 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 515 | 0.240 |
Why?
| | Methemoglobin | 4 | 2021 | 21 | 0.240 |
Why?
| | Vascular Remodeling | 2 | 2019 | 193 | 0.240 |
Why?
| | Circular Dichroism | 2 | 2021 | 149 | 0.230 |
Why?
| | Chromatography, Gel | 5 | 2010 | 127 | 0.230 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5757 | 0.230 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.230 |
Why?
| | Antioxidants | 1 | 2008 | 584 | 0.220 |
Why?
| | Riboflavin | 1 | 2024 | 13 | 0.220 |
Why?
| | Vasoconstriction | 4 | 2020 | 202 | 0.220 |
Why?
| | Vascular Resistance | 2 | 2016 | 375 | 0.220 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 55 | 0.220 |
Why?
| | Aspirin | 2 | 2006 | 387 | 0.210 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2023 | 23 | 0.210 |
Why?
| | Nails | 1 | 2023 | 12 | 0.210 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1724 | 0.210 |
Why?
| | Hemoglobin A | 4 | 2006 | 21 | 0.210 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 927 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 139 | 0.200 |
Why?
| | Perfusion | 1 | 2024 | 213 | 0.200 |
Why?
| | Blood Pressure | 6 | 2018 | 1786 | 0.200 |
Why?
| | Protein Engineering | 2 | 2018 | 97 | 0.200 |
Why?
| | Equidae | 1 | 2022 | 6 | 0.200 |
Why?
| | Species Specificity | 2 | 2020 | 585 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 257 | 0.190 |
Why?
| | Radiation Injuries | 1 | 2023 | 145 | 0.190 |
Why?
| | Superoxides | 1 | 2022 | 202 | 0.190 |
Why?
| | Receptor, PAR-1 | 1 | 2022 | 16 | 0.190 |
Why?
| | Receptors, Thrombin | 1 | 2022 | 13 | 0.190 |
Why?
| | Intestinal Absorption | 1 | 2002 | 102 | 0.190 |
Why?
| | Mycoplasma hyorhinis | 1 | 2021 | 1 | 0.190 |
Why?
| | Fibrinolysis | 2 | 2022 | 146 | 0.180 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.180 |
Why?
| | Magnetics | 1 | 2021 | 48 | 0.180 |
Why?
| | Blood Coagulation Tests | 1 | 2021 | 67 | 0.180 |
Why?
| | Ultraviolet Rays | 1 | 2024 | 396 | 0.180 |
Why?
| | Cell Line | 6 | 2015 | 2847 | 0.180 |
Why?
| | Tranexamic Acid | 1 | 2021 | 40 | 0.180 |
Why?
| | Methemalbumin | 1 | 2021 | 1 | 0.180 |
Why?
| | Photoelectron Spectroscopy | 1 | 2021 | 6 | 0.180 |
Why?
| | Antifibrinolytic Agents | 1 | 2021 | 51 | 0.180 |
Why?
| | Models, Biological | 4 | 2018 | 1783 | 0.180 |
Why?
| | Factor VIII | 1 | 2021 | 98 | 0.180 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1086 | 0.170 |
Why?
| | Free Radicals | 4 | 2015 | 110 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 65 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.170 |
Why?
| | Polymerization | 3 | 2023 | 124 | 0.170 |
Why?
| | Lung Transplantation | 1 | 2024 | 313 | 0.170 |
Why?
| | Beta vulgaris | 1 | 2020 | 12 | 0.170 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 35 | 0.170 |
Why?
| | CD40 Antigens | 1 | 2021 | 89 | 0.170 |
Why?
| | Pharmaceutical Preparations | 1 | 2002 | 179 | 0.160 |
Why?
| | Subarachnoid Space | 1 | 2019 | 8 | 0.160 |
Why?
| | Hypertension | 3 | 2020 | 1295 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 91 | 0.160 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 17 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 71 | 0.160 |
Why?
| | Protein Unfolding | 1 | 2019 | 31 | 0.160 |
Why?
| | Biotechnology | 1 | 2019 | 42 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 72 | 0.160 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 114 | 0.160 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 41 | 0.160 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 66 | 0.150 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 316 | 0.150 |
Why?
| | Blotting, Western | 5 | 2015 | 1226 | 0.150 |
Why?
| | Nitrates | 2 | 2020 | 92 | 0.150 |
Why?
| | Ferritins | 2 | 2010 | 64 | 0.150 |
Why?
| | Osmotic Fragility | 2 | 2024 | 10 | 0.150 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2019 | 42 | 0.150 |
Why?
| | Cell Communication | 1 | 2020 | 315 | 0.150 |
Why?
| | Antibodies | 1 | 2021 | 410 | 0.150 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.150 |
Why?
| | Erythropoietin | 2 | 2018 | 95 | 0.150 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2607 | 0.150 |
Why?
| | Healthy Volunteers | 1 | 2019 | 199 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 180 | 0.150 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 665 | 0.150 |
Why?
| | Fibrin | 1 | 2019 | 81 | 0.150 |
Why?
| | Lipocalin-2 | 1 | 2018 | 79 | 0.150 |
Why?
| | Plasma | 1 | 2020 | 212 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2018 | 160 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 170 | 0.140 |
Why?
| | Metabolic Clearance Rate | 2 | 2012 | 115 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 2018 | 80 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2019 | 198 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 345 | 0.140 |
Why?
| | Liver Diseases | 1 | 2021 | 315 | 0.140 |
Why?
| | Temperature | 1 | 2021 | 679 | 0.140 |
Why?
| | Hepcidins | 2 | 2015 | 22 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 976 | 0.140 |
Why?
| | Female | 16 | 2023 | 73304 | 0.140 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 123 | 0.140 |
Why?
| | Physical Exertion | 1 | 2018 | 215 | 0.130 |
Why?
| | Solutions | 2 | 2010 | 168 | 0.130 |
Why?
| | Oxymorphone | 1 | 2016 | 3 | 0.130 |
Why?
| | Metabolomics | 4 | 2025 | 678 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2019 | 10811 | 0.130 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 32 | 0.130 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 332 | 0.130 |
Why?
| | Dogs | 3 | 2022 | 413 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 208 | 0.130 |
Why?
| | Proteins | 1 | 2023 | 1009 | 0.130 |
Why?
| | Disease Management | 1 | 2020 | 628 | 0.130 |
Why?
| | Swine | 4 | 2021 | 775 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1774 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 530 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 804 | 0.120 |
Why?
| | Microcirculation | 2 | 2020 | 149 | 0.120 |
Why?
| | Sepsis | 2 | 2020 | 617 | 0.120 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 107 | 0.120 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.120 |
Why?
| | Disease Progression | 3 | 2023 | 2757 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Heart | 1 | 2019 | 655 | 0.120 |
Why?
| | Protein Stability | 3 | 2012 | 176 | 0.120 |
Why?
| | Splenomegaly | 1 | 2015 | 15 | 0.120 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 22 | 0.120 |
Why?
| | Muscle Contraction | 1 | 2018 | 424 | 0.110 |
Why?
| | Cardiac Output | 2 | 2012 | 165 | 0.110 |
Why?
| | Hemorrhage | 1 | 2019 | 722 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 532 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 145 | 0.110 |
Why?
| | Cell-Free System | 3 | 2011 | 53 | 0.110 |
Why?
| | Altitude | 1 | 2018 | 488 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2021 | 1043 | 0.110 |
Why?
| | Excipients | 2 | 2024 | 55 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 86 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 231 | 0.100 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 217 | 0.100 |
Why?
| | Creatinine | 2 | 2012 | 499 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.100 |
Why?
| | Models, Molecular | 3 | 2020 | 1570 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 622 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 2057 | 0.100 |
Why?
| | Malaria | 1 | 2013 | 63 | 0.100 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 29 | 0.100 |
Why?
| | Infusion Pumps | 1 | 2012 | 32 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2020 | 1164 | 0.100 |
Why?
| | Transcriptome | 2 | 2018 | 971 | 0.100 |
Why?
| | Spin Labels | 1 | 2012 | 48 | 0.100 |
Why?
| | Neutrophils | 1 | 2018 | 1238 | 0.100 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 12 | 0.090 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2023 | 99 | 0.090 |
Why?
| | Adult | 5 | 2023 | 37929 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Glycolysis | 2 | 2025 | 321 | 0.090 |
Why?
| | Dimerization | 2 | 2010 | 199 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 391 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 222 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 5742 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 24 | 0.090 |
Why?
| | Occludin | 1 | 2011 | 11 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 16 | 0.090 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 18 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 2085 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 87 | 0.090 |
Why?
| | Area Under Curve | 1 | 2012 | 314 | 0.090 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 81 | 0.090 |
Why?
| | Claudins | 1 | 2011 | 25 | 0.090 |
Why?
| | Basilar Artery | 2 | 2021 | 6 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 346 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3556 | 0.080 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 3 | 0.080 |
Why?
| | Filtration | 1 | 2010 | 72 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 138 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1502 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 71 | 0.080 |
Why?
| | Pyridones | 1 | 2011 | 168 | 0.080 |
Why?
| | Fatty Acids | 2 | 2023 | 443 | 0.080 |
Why?
| | Oxygen Consumption | 2 | 2024 | 696 | 0.080 |
Why?
| | Aorta | 1 | 2012 | 417 | 0.080 |
Why?
| | Cellular Senescence | 1 | 2011 | 189 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 415 | 0.080 |
Why?
| | Pneumonia | 1 | 2015 | 639 | 0.080 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 9 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2011 | 338 | 0.070 |
Why?
| | Globins | 1 | 2008 | 22 | 0.070 |
Why?
| | alpha-Globins | 1 | 2008 | 9 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2015 | 4193 | 0.070 |
Why?
| | Buffers | 1 | 2008 | 56 | 0.070 |
Why?
| | Hemin | 2 | 2021 | 4 | 0.070 |
Why?
| | Lasers | 2 | 2005 | 130 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 56 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 446 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2167 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 192 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 167 | 0.070 |
Why?
| | Tissue Engineering | 1 | 2011 | 423 | 0.070 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 491 | 0.060 |
Why?
| | Binding Sites | 2 | 2011 | 1303 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 160 | 0.060 |
Why?
| | Pentetic Acid | 1 | 2005 | 13 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 570 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 346 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 489 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 23 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 128 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 433 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 18 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 204 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2253 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 248 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 101 | 0.060 |
Why?
| | Child | 2 | 2023 | 21935 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 6828 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2025 | 332 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 31 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1670 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2021 | 730 | 0.060 |
Why?
| | Chlorides | 1 | 2005 | 136 | 0.060 |
Why?
| | Peptides | 1 | 2010 | 985 | 0.060 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2024 | 9 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2475 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 176 | 0.050 |
Why?
| | Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
| | Particle Size | 1 | 2005 | 394 | 0.050 |
Why?
| | Acute Disease | 2 | 2021 | 1007 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 822 | 0.050 |
Why?
| | Allografts | 1 | 2024 | 146 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 263 | 0.050 |
Why?
| | Hemoglobin, Sickle | 1 | 2022 | 19 | 0.050 |
Why?
| | Cercopithecidae | 1 | 2002 | 9 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 206 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 474 | 0.050 |
Why?
| | Drug Compounding | 1 | 2022 | 101 | 0.050 |
Why?
| | Risk Assessment | 1 | 2012 | 3457 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2022 | 155 | 0.050 |
Why?
| | Hand | 1 | 2023 | 156 | 0.050 |
Why?
| | Biological Availability | 1 | 2002 | 148 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2024 | 1092 | 0.050 |
Why?
| | Horses | 1 | 2022 | 111 | 0.050 |
Why?
| | Protein Conformation | 1 | 2005 | 934 | 0.050 |
Why?
| | Serum Albumin, Human | 1 | 2021 | 6 | 0.050 |
Why?
| | Young Adult | 1 | 2018 | 13209 | 0.050 |
Why?
| | Platelet Activation | 1 | 2022 | 93 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2022 | 103 | 0.040 |
Why?
| | Etanercept | 1 | 2021 | 57 | 0.040 |
Why?
| | Cell Survival | 2 | 2018 | 1120 | 0.040 |
Why?
| | Nitrites | 2 | 2013 | 84 | 0.040 |
Why?
| | Triage | 1 | 2023 | 222 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 53 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 967 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 84 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 224 | 0.040 |
Why?
| | ADAMTS13 Protein | 1 | 2020 | 7 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 283 | 0.040 |
Why?
| | Kynurenine | 1 | 2021 | 114 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 558 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 563 | 0.040 |
Why?
| | Mesocricetus | 1 | 2020 | 39 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 33479 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1946 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 80 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 183 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 105 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 289 | 0.040 |
Why?
| | Administration, Oral | 1 | 2002 | 816 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 209 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 41 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 305 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 92 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 60 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 156 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 82 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 166 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 187 | 0.040 |
Why?
| | Transfection | 1 | 2021 | 945 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 97 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 597 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 65 | 0.040 |
Why?
| | Tissue Donors | 1 | 2021 | 425 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 408 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 238 | 0.040 |
Why?
| | Blood Safety | 1 | 2017 | 11 | 0.040 |
Why?
| | Hemodilution | 2 | 2008 | 10 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 513 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 75 | 0.040 |
Why?
| | Vasodilation | 1 | 2021 | 499 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 92 | 0.030 |
Why?
| | Precision Medicine | 1 | 2022 | 429 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 350 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 20 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 861 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 856 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2139 | 0.030 |
Why?
| | Acclimatization | 1 | 2018 | 177 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 16 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1719 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1710 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 493 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1062 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 561 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 181 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 1993 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 107 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 70 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 93 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2833 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 382 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 578 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 788 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 413 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2553 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 374 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.030 |
Why?
| | Body Mass Index | 1 | 2021 | 2389 | 0.020 |
Why?
| | Mitochondria | 1 | 2019 | 948 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 116 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 778 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 168 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 5 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.020 |
Why?
| | Phagocytosis | 1 | 2014 | 380 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1477 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 24 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 12 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 39 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 420 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 114 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 90 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 52 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 42 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 560 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 664 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 374 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 100 | 0.020 |
Why?
| | Tight Junctions | 1 | 2011 | 76 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2900 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 886 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 3 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 26 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 246 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3015 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 201 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 7 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3196 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 21 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 84 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7604 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 210 | 0.020 |
Why?
| | Canada | 1 | 2010 | 418 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 356 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 261 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 240 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 767 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2668 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 226 | 0.020 |
Why?
| | Heart Failure | 1 | 2021 | 2236 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 19 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 55 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 893 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 13 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 38 | 0.020 |
Why?
| | Rabbits | 1 | 2006 | 794 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 594 | 0.010 |
Why?
| | Endocytosis | 1 | 2005 | 172 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 375 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 136 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1457 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 706 | 0.010 |
Why?
| | United States | 1 | 2017 | 14841 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|